{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T17:31:24Z","timestamp":1767893484384,"version":"3.49.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,6,14]],"date-time":"2021-06-14T00:00:00Z","timestamp":1623628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,6,14]],"date-time":"2021-06-14T00:00:00Z","timestamp":1623628800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s00428-021-03138-x","type":"journal-article","created":{"date-parts":[[2021,6,14]],"date-time":"2021-06-14T19:02:42Z","timestamp":1623697362000},"page":"487-492","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["EZR-ROS1 fusion renal cell carcinoma mimicking urothelial carcinoma: report of a previously undescribed gene fusion in renal cell carcinoma"],"prefix":"10.1007","volume":"480","author":[{"given":"Antic","family":"Tatjana","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5869-3175","authenticated-orcid":false,"given":"Melissa Y.","family":"Tjota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter H.","family":"O\u2019Donnell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott E.","family":"Eggener","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piyush K.","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rishikesh","family":"Haridas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremy","family":"Segal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,6,14]]},"reference":[{"key":"3138_CR1","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1007\/s00345-018-2447-8","volume":"36","author":"AY Warren","year":"2018","unstructured":"Warren AY, Harrison D (2018) WHO\/ISUP classification, grading and pathological staging of renal cell carcinoma: standards and controversies. World J Urol 36:1913\u20131926. https:\/\/doi.org\/10.1007\/s00345-018-2447-8","journal-title":"World J Urol"},{"key":"3138_CR2","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/j.eururo.2005.11.035","volume":"49","author":"A Lopez-Beltran","year":"2006","unstructured":"Lopez-Beltran A, Scarpelli M, Montironi R, Kirkali Z (2006) 2004 WHO classification of the renal tumors of the adults. Eur Urol 49:798\u2013805. https:\/\/doi.org\/10.1016\/j.eururo.2005.11.035","journal-title":"Eur Urol"},{"key":"3138_CR3","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1200\/JCO.2011.35.6345","volume":"30","author":"K Bergethon","year":"2012","unstructured":"Bergethon K, Shaw AT, Ou S-HI, Katayama R, Lovly CM, McDonald NT et al (2012) ROS1 rearrangements define a unique molecular class of lung cancers. J Clin Oncol Off J Am Soc Clin Oncol 30:863\u2013870. https:\/\/doi.org\/10.1200\/JCO.2011.35.6345","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"3138_CR4","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jmoldx.2016.07.012","volume":"19","author":"S Kadri","year":"2017","unstructured":"Kadri S, Long BC, Mujacic I, Zhen CJ, Wurst MN, Sharma S et al (2017) Clinical validation of a next-generation sequencing genomic oncology panel via cross-platform benchmarking against established amplicon sequencing assays. J Mol Diagn JMD 19:43\u201356. https:\/\/doi.org\/10.1016\/j.jmoldx.2016.07.012","journal-title":"J Mol Diagn JMD"},{"key":"3138_CR5","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.humpath.2020.10.013","volume":"107","author":"S Gupta","year":"2020","unstructured":"Gupta S, Cheville JC, Galeano BK, Sukov WR, Herrera-Hernandez L, Reed KA et al (2020) Renal neoplasia with papillary architecture involving the pelvicalyceal system. Hum Pathol 107:46\u201357. https:\/\/doi.org\/10.1016\/j.humpath.2020.10.013","journal-title":"Hum Pathol"},{"key":"3138_CR6","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/0165-4608(92)90388-o","volume":"63","author":"AM Meloni","year":"1992","unstructured":"Meloni AM, Sandberg AA, Pontes JE, Dobbs RM (1992) Translocation (X;1)(p11.2;q21). A subtype of renal adenocarcinomas. Cancer Genet Cytogenet 63:100\u2013101. https:\/\/doi.org\/10.1016\/0165-4608(92)90388-o","journal-title":"Cancer Genet Cytogenet"},{"key":"3138_CR7","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1111\/his.13167","volume":"70","author":"M Classe","year":"2017","unstructured":"Classe M, Malouf GG, Su X, Yao H, Thompson EJ, Doss DJ et al (2017) Incidence, clinicopathological features and fusion transcript landscape of translocation renal cell carcinomas. Histopathology 70:1089\u20131097. https:\/\/doi.org\/10.1111\/his.13167","journal-title":"Histopathology"},{"key":"3138_CR8","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1097\/PAS.0000000000000927","volume":"41","author":"T Antic","year":"2017","unstructured":"Antic T, Taxy JB, Alikhan M, Segal J (2017) Melanotic translocation renal cell carcinoma with a novel ARID1B-TFE3 gene fusion. Am J Surg Pathol 41:1576\u20131580. https:\/\/doi.org\/10.1097\/PAS.0000000000000927","journal-title":"Am J Surg Pathol"},{"key":"3138_CR9","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1097\/PAS.0000000000000730","volume":"41","author":"K Pivovarcikova","year":"2017","unstructured":"Pivovarcikova K, Grossmann P, Alaghehbandan R, Sperga M, Michal M, Hes O (2017) TFE3-fusion variant analysis defines specific clinicopathologic associations Amog Xp11 translocation cancers. Am J Surg Pathol 41:138\u2013140. https:\/\/doi.org\/10.1097\/PAS.0000000000000730","journal-title":"Am J Surg Pathol"},{"key":"3138_CR10","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1097\/PAS.0000000000001408","volume":"44","author":"Q-Y Xia","year":"2020","unstructured":"Xia Q-Y, Wang X-T, Fang R, Wang Z, Zhao M, Chen H et al (2020) Clinicopathologic and molecular analysis of the TFEB fusion variant reveals new members of TFEB translocation renal cell carcinomas (RCCs): expanding the genomic spectrum. Am J Surg Pathol 44:477\u2013489. https:\/\/doi.org\/10.1097\/PAS.0000000000001408","journal-title":"Am J Surg Pathol"},{"key":"3138_CR11","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1097\/JTO.0b013e31826baf83","volume":"7","author":"LP Chin","year":"2012","unstructured":"Chin LP, Soo RA, Soong R, Ou S-HI (2012) Targeting ROS1 with anaplastic lymphoma kinase inhibitors: a promising therapeutic strategy for a newly defined molecular subset of non\u2013small-cell lung cancer. J Thorac Oncol 7:1625\u20131630. https:\/\/doi.org\/10.1097\/JTO.0b013e31826baf83","journal-title":"J Thorac Oncol"},{"key":"3138_CR12","doi-asserted-by":"publisher","first-page":"e56010","DOI":"10.1371\/journal.pone.0056010","volume":"8","author":"Y Arai","year":"2013","unstructured":"Arai Y, Totoki Y, Takahashi H, Nakamura H, Hama N, Kohno T et al (2013) Mouse model for ROS1-rearranged lung cancer. PLoS ONE 8:e56010. https:\/\/doi.org\/10.1371\/journal.pone.0056010","journal-title":"PLoS ONE"},{"key":"3138_CR13","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1056\/NEJMoa1214886","volume":"368","author":"AT Shaw","year":"2013","unstructured":"Shaw AT, Kim D-W, Nakagawa K, Seto T, Crin\u00f3 L, Ahn M-J et al (2013) Crizotinib versus chemotherapy in advanced ALK-positive lung cancer. N Engl J Med 368:2385\u20132394. https:\/\/doi.org\/10.1056\/NEJMoa1214886","journal-title":"N Engl J Med"},{"key":"3138_CR14","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12890-018-0585-9","volume":"18","author":"L Dong","year":"2018","unstructured":"Dong L, Xia J, Zhang J, Zhang Y, Zhu N, Zhang P et al (2018) Long-term progression-free survival in an advanced lung adenocarcinoma patient harboring EZR-ROS1 rearrangement: a case report. BMC Pulm Med 18:13. https:\/\/doi.org\/10.1186\/s12890-018-0585-9","journal-title":"BMC Pulm Med"},{"key":"3138_CR15","doi-asserted-by":"publisher","unstructured":"Liu SV, Macke LA, Colton BS, Imran SS, Christiansen J, Chow-Maneval E, et al (2017) Response to entrectinib in differentiated thyroid cancer with a ROS1 fusion. JCO Precis Oncol 1. https:\/\/doi.org\/10.1200\/PO.17.00105","DOI":"10.1200\/PO.17.00105"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-021-03138-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-021-03138-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-021-03138-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T12:09:10Z","timestamp":1649246950000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-021-03138-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,14]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["3138"],"URL":"https:\/\/doi.org\/10.1007\/s00428-021-03138-x","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,14]]},"assertion":[{"value":"16 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}